Are you a clinical specialist involved in the diagnosis and management of patients with suspected dementia?
Are you a clinical specialist involved in the diagnosis and management of patients with suspected dementia?
Photo: Designed by Freepik
Published 6 March 2025
Share this article
PREDICTOM is inviting clinical specialists (aka secondary and tertiary care physicians) to complete this short survey. We want to hear about your current clinical practice when managing patients who you suspect have dementia. We also ask some questions about Alzheimer’s disease and mild cognitive impairment.
Your responses will help us develop recommendations for optimising clinical practice guidelines, considering new technologies to support diagnosis and facilitators and barriers to implementation.
In a breakthrough that could reshape early detection of Alzheimer’s disease, researchers have identified a novel blood-based biomarker that may help distinguish Alzheimer’s patients from healthy individuals—potentially paving the way for simpler, less invasive diagnostics.
PREDICTOM has unveiled a standardized MRI protocol designed to identify early biomarkers of Alzheimer’s disease. With dementia cases in the EU projected to double by 2050, early detection is more critical than ever.
